Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity
Open accessThe DOI matches its Crossref record; 57 of the 58 references it cites were found in a registry or an index.
Abstract
Elucidating the signalling mechanisms by which obesity leads to impaired insulin action is critical in the development of therapeutic strategies for the treatment of diabetes. Recently, mice deficient for S6 Kinase 1 (S6K1), an effector of the mammalian target of rapamycin (mTOR) that acts to integrate nutrient and insulin signals, were shown to be hypoinsulinaemic, glucose intolerant and have reduced beta-cell mass. However, S6K1-deficient mice maintain normal glucose levels during fasting, suggesting hypersensitivity to insulin, raising the question of their metabolic fate as a function of age and diet. Here, we report that S6K1-deficient mice are protected against obesity owing to enhanced beta-oxidation. However on a high fat diet, levels of glucose and free fatty acids still rise in S6K1-deficient mice, resulting in insulin receptor desensitization. Nevertheless, S6K1-deficient mice remain sensitive to insulin owing to the apparent loss of a negative feedback loop from S6K1 to insulin receptor substrate 1 (IRS1), which blunts S307 and S636/S639 phosphorylation; sites involved in insulin resistance. Moreover, wild-type mice on a high fat diet as well as K/K A(y) and ob/ob (also known as Lep/Lep) mice-two genetic models of obesity-have markedly elevated S6K1 activity and, unlike S6K1-deficient mice, increased phosphorylation of IRS1 S307 and S636/S639. Thus under conditions of nutrient satiation S6K1 negatively regulates insulin signalling.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We discuss how pathways that “sense” nutrients within skeletal muscle are readily able to regulate insulin action.”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [37]
In the citing paper
“The mTOR/ p70S6 kinase pathway is a putative nutrient-sensing pathway, and overactivation of this pathway in cell-based systems, rodents, and humans is also associated with insulin resistance (37)(38)(39).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [37]
In the citing paper
“Obese and type 2 diabetic rodents have increased mTOR/S6K signaling and this may contribute to insulin resistance [151-153].”
From AMPK and Exercise: Glucose Uptake and Insulin Sensitivity (2013) · cites this paper as [151]
Citations
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419 · cited 1×
“To test this further, two genetic models of obesity were examined: K/K A y and ob/ob mic”
MethodMootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Insulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326 · cited 1×
“gif" NDATA ITEM> ]> Elucidating the signalling mechanisms by which obesity leads to impaired insulin action is critical in the development of therapeutic strategies for the treatment of diabete”
BackgroundA central role for JNK in obesity and insulin resistance
Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359 · cited 1×
“Protein extracts from tissue samples were analysed as describe”
MethodObesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,225
Patti, M. E., Butte, A. J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., Miyazaki, Y., Kohane, I., Costello, M., Saccone, R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1032913100 · Cited by 1,952
The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys
Stremlau, M., Owens, C. M., Perron, M. J., Kiessling, M., Autissier, P., & Sodroski, J. (2004) · Nature · doi:10.1038/nature02343 · Cited by 1,816
Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diab.46.1.3 · Cited by 1,728 · cited 1×
“As increased circulating FFAs are implicated in insulin resistanc”
BackgroundHara, K., Yonezawa, K., Weng, Q.-P., Kozlowski, M. T., Belham, C., & Avruch, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.23.14484 · Cited by 1,367
Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E
Fingar, D. C., Salama, S., Tsou, C., Harlow, E., & Blenis, J. (2002) · Genes & Development · doi:10.1101/gad.995802 · Cited by 1,093 · cited 4×
“a, S6K1 Thr 389 and S6 Ser 240/244 phosphorylation in fat of wild-type mice maintained on a NCD (2) or HFD (þ) for 4 months.”
BackgroundMethodInfluential
Cited by
Items 501–600 of 1,004
Turdi, S., Ge, W., Hu, N., Bradley, K. M., Wang, X., & Ren, J. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.12.007 · Cited by 88
“In our hand, Ser phosphorylation of IRS-1 was significantly enhanced in MHPH group, consistent with the notion that nutritional excess may promote Ser phosphorylation of IRS-1 [52].”
BackgroundGonzález‐Rodríguez, Á., Mas‐Gutierrez, J. A., Mirasierra, M., Fernández-Pérez, A., Lee, Y. J., Ko, H. J., Kim, J. K., Romanos, E., Carrascosa, J. M., Ros, M., et al. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2011.00786.x · Cited by 99
“This was because of increased basal S6K1 activity which leads to IRS1 serine phosphorylation and disruption of PI 3-kinase activation, thereby limiting the effects of insulin on fatty acid uptake and lipolysis (Um et al., 2004).”
BackgroundTORC2 Regulates Hepatic Insulin Signaling via a Mammalian Phosphatidic Acid Phosphatase, LIPIN1
Ryu, D., Oh, K., Jo, H.-Y., Hedrick, S. A., Kim, Y.-N., Hwang, Y.-J., Park, T., Han, J., Choi, C. S., Montminy, M., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.01.007 · Cited by 91
“…were proposed to be major signaling molecules for activating serine/threonine kinases such as JNK, noncanonical PKC, S6K, or mTOR to target IR or IR substrates to hamper insulin signaling in the cell (Jaeschke and Davis, 2007; Nguyen et al., 2005; Samuel et al., 2004, 2007; Um et al., 2004, 2006).”
BackgroundAbnormal protein turnover and anabolic resistance to exercise in sarcopenic obesity
Nilsson, M. I., Dobson, J. P., Greene, N. P., Wiggs, M. P., Shimkus, K. L., Wudeck, E. V., Davis, A. R., Laureano, M. L., & Fluckey, J. D. (2013) · The FASEB Journal · doi:10.1096/fj.12-224006 · Cited by 87
DEPTOR at the Nexus of Cancer, Metabolism, and Immunity
Caron, A., Briscoe, D. M., Richard, D., & Laplante, M. (2018) · Physiological Reviews · doi:10.1152/physrev.00064.2017 · Cited by 94
Mitochondria and Organismal Longevity
Hwang, A. B., Jeong, D., & Lee, S. (2012) · Current Genomics · doi:10.2174/138920212803251427 · Cited by 96
Mordier, S., & Iynedjian, P. B. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.08.004 · Cited by 99
Glucose-regulated Glucagon Secretion Requires Insulin Receptor Expression in Pancreatic α-Cells
Diao, J., Asghar, Z., Chan, C. B., & Wheeler, M. B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506276200 · Cited by 88
The Emerging Role of Branched-Chain Amino Acids in Liver Diseases
Lo, E. K. K., Felicianna, Xu, J., Zhan, Q., Zeng, Z., & El-Nezami, H. S. (2022) · Biomedicines · doi:10.3390/biomedicines10061444 · Cited by 94
RagA, but Not RagB, Is Essential for Embryonic Development and Adult Mice
Efeyan, A., Schweitzer, L. D., Bilate, A. M., Chang, S., Kirak, O., Lamming, D. W., & Sabatini, D. M. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.03.017 · Cited by 90
“This result also shows the strong negative regulation that mTORC1 has on Akt activation, as shown previously (Harrington et al., 2004; Haruta et al., 2000; Um et al., 2004).”
ResultAgeing and metabolism: drug discovery opportunities
Curtis, R., Geesaman, B. J., & DiStefano, P. S. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1777 · Cited by 98
Kim, K., Pyo, S., & Um, S. H. (2012) · Hepatology · doi:10.1002/hep.25537 · Cited by 89
“Mice lacking S6K1 exhibit increased energy expenditure and lipolysis and are protected from diet-induced obesity and insulin resistance.(11,12) In contrast, mice lacking 4EBP1 and 2 display elevated sensitivity to diet-induced obesity and insulin resistance, along with increased S6K1 activity, underscoring the importa…”
BackgroundMethodSelf-citationEffects of dietary protein on glucose homeostasis
Promintzer, M., & Krebs, M. (2006) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000232909.84483.a9 · Cited by 84
S6K1 Phosphorylation of H2B Mediates EZH2 Trimethylation of H3: A Determinant of Early Adipogenesis
Yi, S. A., Um, S. H., Lee, J., Yoo, J. H., Bang, S. Y., Park, E. K., Lee, M. G., Nam, K. H., Jeon, Y. J., Park, J. W., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.03.011 · Cited by 86
“, 2012), consistent with S6K1-deficient mice being lean at birth, exhibiting reduced adipocyte cell size and resistance to high-fat diet (HFD)-induced obesity (Um et al., 2004).”
InfluentialSelf-citationYe, L., Varamini, B., Lamming, D. W., Sabatini, D. M., & Baur, J. A. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00177 · Cited by 79
Autophagy, signaling and obesity
Lavallard, V., Meijer, A. J., Codogno, P., & Gual, P. (2012) · Pharmacological Research · doi:10.1016/j.phrs.2012.09.003 · Cited by 93
mTOR/S6 Kinase Pathway Contributes to Astrocyte Survival during Ischemia
Pastor, M. D., García-Yébenes, I., Fradejas, N., Pérez-Ortiz, J. M., Mora-Lee, S., Tranque, P., Moro, M. Á., Pende, M., & Calvo, S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.033100 · Cited by 85
Mammalian target of rapamycin (mTOR) as a potential therapeutic target in various diseases
Kaur, A., & Sharma, S. (2017) · Inflammopharmacology · doi:10.1007/s10787-017-0336-1 · Cited by 93
“The increased activation of mTORC1 in muscles of obese and high-fat given rodents operates S6K1- mediated feedback inhibition of insulin signaling, which decreases glucose uptake by the muscle and gives rise to systemic insulin resistance (Khamzina et al. 2005; Um et al. 2004).”
InfluentialZhang, Z., Yang, D., Xiang, J., Zhou, J., Cao, H., Che, Q., Bai, Y., Guo, J., & Su, Z. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.60354 · Cited by 90
“Similarly, white adipocytes of S6K1-/- mice also showed increased UCP1 expression [62].”
BackgroundDysregulation of Lipid and Glucose Metabolism in Nonalcoholic Fatty Liver Disease
Bhat, N., & Mani, A. (2023) · Nutrients · doi:10.3390/nu15102323 · Cited by 92
“S6K1 promotes the inhibitory serine phosphorylation of insulin receptor substrate 1 (IRS1) [68,69].”
BackgroundBusschots, K., Lopez-Garcia, L. A., Lammi, C., Stroba, A., Zeuzem, S., Piiper, A., Alzari, P. M., Neimanis, S., Arencibia, J. M., Engel, M., et al. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.07.017 · Cited by 88
“Phosphorylation of IRS1 by S6K acts as a negative feedback loop, inhibiting PI3-kinase downstream signaling (Tremblay et al., 2007; Um et al., 2004).”
BackgroundS6 kinase 1 is required for rapamycin-sensitive liver proliferation after mouse hepatectomy
Espeillac, C., Mitchell, C., Celton-Morizur, S., Chauvin, C., Koka, V., Gillet, C., Albrecht, J. H., Desdouets, C., & Pende, M. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44203 · Cited by 80
Marshall, L., Rideout, E. J., & Grewal, S. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.33 · Cited by 92
“Genetic inhibition of either TOR and S6K in mice leads to alterations in metabolic activity in adipose tissue (Um et al , 2004, 2006; Polak et al , 2008; Cybulski et al , 2009).”
Drummond, M. J., Bell, J. A., Fujita, S., Dreyer, H. C., Glynn, E. L., Volpi, E., & Rasmussen, B. B. (2008) · Clinical Nutrition · doi:10.1016/j.clnu.2008.01.012 · Cited by 94
Kazior, Z., Willis, S. J., Moberg, M., Apró, W., Calbet, J. A. L., Holmberg, H.-C., & Blomstrand, E. (2016) · PLOS ONE · doi:10.1371/journal.pone.0149082 · Cited by 82
“Although, the reason for the divergent regulation of these proteins is unclear, it is possible that up-regulation of S6K1 may amplify its inhibitory feedback on the insulin receptor substrate (IRS) 1, which impairs the activation of phosphoinositide 3-kinase (PI3K) and Akt [50, 51].”
BackgroundAdaptation to mTOR kinase inhibitors by amplification of eIF4E to maintain cap-dependent translation
Cope, C. L., Gilley, R., Balmanno, K., Sale, M. J., Howarth, K. D., Hampson, M., Smith, P. D., Guichard, S. M., & Cook, S. J. (2013) · Journal of Cell Science · doi:10.1242/jcs.137588 · Cited by 79
Williams, K. J., & Wu, X. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.02.004 · Cited by 87
Vlavcheski, F., Hartogh, D. J. D., Giacca, A., & Tsiani, E. (2020) · Nutrients · doi:10.3390/nu12040914 · Cited by 260
“phosphorylation of IRS-1, resulting in impaired insulin signaling and insulin resistance [26].”
BackgroundResultInfluentialShinozaki, S., Choi, C. S., Shimizu, N., Yamada, M., Kim, M., Zhang, T., Shiota, G., Dong, H. H., Kim, Y.-B., & Kaneki, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.187666 · Cited by 90
Veilleux, A., Houde, V. P., Bellmann, K., & Marette, A. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0328 · Cited by 95
Metabolic Crosstalk: Molecular Links Between Glycogen and Lipid Metabolism in Obesity
Lu, B., Bridges, D., Yang, Y., Fisher, K., Cheng, A., Chang, L. C., Meng, Z., Lin, J. D., Downes, M., Yu, R. T., et al. (2014) · Diabetes · doi:10.2337/db13-1531 · Cited by 88
“Over time, this modulation of metabolic activity also leads to dramatically improved insulin sensitivity in the KO mice, perhaps through reductions in mTORC1 activity known to negatively regulate insulin receptor signaling (21,22).”
BackgroundmTOR Signaling Confers Resistance to Targeted Cancer Drugs
Guri, Y., & Hall, M. N. (2016) · Trends in cancer · doi:10.1016/j.trecan.2016.10.006 · Cited by 85
The PI3K and MAPK/p38 pathways control stress granule assembly in a hierarchical manner
Heberle, A. M., Navas, P. R., Langelaar‐Makkinje, M., Kasack, K., Sadik, A., Faessler, E., Hahn, U., Marx‐Stoelting, P., Opitz, C. A., Sers, C., et al. (2019) · Life Science Alliance · doi:10.26508/lsa.201800257 · Cited by 85
Zhu, Y., Pereira, R. O., O'Neill, B. T., Riehle, C., Ilkun, O. L., Wende, A. R., Rawlings, T. A., Zhang, Y. C., Zhang, Q., Klip, A., et al. (2012) · Molecular Endocrinology · doi:10.1210/me.2012-1210 · Cited by 82
FABP4 reversed the regulation of leptin on mitochondrial fatty acid oxidation in mice adipocytes
Gan, L., Liu, Z., Cao, W., Zhang, Z., & Sun, C. (2015) · Scientific Reports · doi:10.1038/srep13588 · Cited by 84
Regulation of adiponectin secretion by insulin and amino acids in 3T3-L1 adipocytes
Blümer, R. M. E., van Roomen, C. P. A. A., Meijer, A. J., Houben-Weerts, J. H. P. M., Sauerwein, H. P., & Dubbelhuis, P. F. (2008) · Metabolism · doi:10.1016/j.metabol.2008.07.020 · Cited by 86
“It was shown recently that overactivation of mTOR signaling by amino acids inhibits insulin signaling upstream of mTOR by a negative feedback effect because of p70S6k-dependent phosphorylation of IRS1, which results in decreased activity of PI3K [31,32].”
BackgroundMammalian TOR signaling to the AGC kinases
Su, B., & Jacinto, E. (2011) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2011.618113 · Cited by 85
“This phosphorylation is abrogated in S6K1 null mice (Um et al., 2004).”
BackgroundMusial, B., Vaughan, O. R., Fernandez‐Twinn, D. S., Voshol, P., Ozanne, S. E., Fowden, A. L., & Sferruzzi‐Perri, A. N. (2017) · The Journal of Physiology · doi:10.1113/jp273684 · Cited by 80
“In non-pregnant animals, insulin resistance and altered insulin signalling in these tissues are observed in response to feeding Western-style diets high in fat and sugar (HFHS) (Um et al. 2004; Wang et al. 2015; Zhang et al. 2015).”
BackgroundOGT suppresses S6K1-mediated macrophage inflammation and metabolic disturbance
Yang, Y., Li, X., Luan, H. H., Zhang, B., Zhang, K., Nam, J. H., Li, Z., Fu, M., Munk, A., Zhang, D., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1916121117 · Cited by 81
“Several studies have suggested that obesity is associated with increased mTOR activity, and deficiency of the downstream mediator S6K1 can protect mice against diet- and age-induced insulin resistance (73, 74).”
BackgroundLiu, W., Singh, R., Choi, C. S., Lee, H.-Y., Keramati, A. R., Samuel, V. T., Lifton, R. P., Shulman, G. I., & Mani, A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.286724 · Cited by 76
“S6K / mice are sensitive to insulin due to increased IRS1 expression and activity (32).”
BackgroundChronic activation of mTOR complex 1 by branched chain amino acids and organ hypertrophy
Neishabouri, S. H., Hutson, S. M., & Davoodi, J. (2015) · Amino Acids · doi:10.1007/s00726-015-1944-y · Cited by 82
“Another possibility stems from the observation that leucine activated mTORC1 can phosphorylate IRS1 effectively blocking the stimulatory effect of insulin (Um et al. 2004).”
BackgroundMolecular mechanisms for anti‐aging by natural dietary compounds
Pan, M., Lai, C., Tsai, M., Wu, J.-C., & Ho, C. (2011) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100509 · Cited by 86
“In S6K1 gene deletion mice, against obesity and enhancing insulin sensitivity were occurred in high-fat diet administration [47].”
BackgroundS6K2: The Neglected S6 Kinase Family Member
Pardo, O. E., & Seckl, M. J. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00191 · Cited by 86
“Conversely, silencing of S6K1 using siRNAs was shown to decrease IRS-1 phosphorylation on several serine residues leading to an increase in PI3K/AKT signaling (93).”
BackgroundBaba, T., Shimizu, T., Suzuki, Y.-I., Ogawara, M., Isono, K.-I., Koseki, H., Kurosawa, H., & Shirasawa, T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500924200 · Cited by 77
Bakker, L. E. H., van Schinkel, L. D., Guigas, B., Streefland, T. C. M., Jonker, J. T., van Klinken, J. B., van der Zon, G. C. M., Lamb, H. J., Smit, J. W. A., Pijl, H., et al. (2014) · Diabetes · doi:10.2337/db13-0696 · Cited by 77
“Indeed, there is growing evidence that mTORC1 suppresses fatty acid beta-oxidation (21,23,24).”
BackgroundInfluentialLuteolin Protects Against CIRI, Potentially via Regulation of the SIRT3/AMPK/mTOR Signaling Pathway
Liu, S., Su, Y., Sun, B., Hao, R., Pan, S., Gao, X., Dong, X., Ismail, A. M., & Han, B. (2020) · Neurochemical Research · doi:10.1007/s11064-020-03108-w · Cited by 81
Oldham, S. (2011) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2010.11.002 · Cited by 82
Skeletal muscle mTORC1 regulates neuromuscular junction stability
Baraldo, M., Geremia, A., Pirazzini, M., Nogara, L., Solagna, F., Türk, C., Nolte, H., Romanello, V., Megighian, A., Boncompagni, S., et al. (2020) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12496 · Cited by 76
Adipose stress-sensing kinases: linking obesity to malfunction
Rudich, A., Kanety, H., & Bashan, N. (2007) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2007.08.006 · Cited by 82
The role of mTOR in the adaptation and failure of β‐cells in type 2 diabetes
Leibowitz, G., Cerasi, E., & Ketzinel‐Gilad, M. (2008) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00952.x · Cited by 74
Global IRS-1 phosphorylation analysis in insulin resistance
Langlais, P. R., Yi, Z., Finlayson, J., Luo, M., Mapes, R., Filippis, E. D., Meyer, C., Plummer, E., Tongchinsub, P., Mattern, M., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2271-9 · Cited by 83
“As for the type 2 diabetic muscle, Ser323 (murine/rat Ser318) was the prominent, hyperphosphorylated site located near the N-terminal PTB domain of IRS-1, potentially phosphorylated by kinases (p70S6K, protein kinase C [PKC]ζ, c-Jun N-terminal kinase [JNK], PKCθ, inhibitor κB kinase [IKKβ]) that can be activated by in…”
Loss of Akt1 in Mice Increases Energy Expenditure and Protects against Diet-Induced Obesity
Wan, M., Easton, R., Gleason, C. E., Monks, B. R., Ueki, K., Kahn, C. R., & Birnbaum, M. J. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05806-11 · Cited by 80
Jeong, Y., Kim, Y. D., Jung, Y., Park, D., Lee, D.-S., Ku, S., Li, X., Lü, Y., Chao, G. H., Kim, K., et al. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.085100 · Cited by 82
“Histologic analysis was performed as described previously (Hong et al., 2004; Villena et al., 2004).”
MethodDeoxyribonucleotide Triphosphate Metabolism in Cancer and Metabolic Disease
Buj, R., & Aird, K. M. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00177 · Cited by 76
“Additionally, deregulation of these pathways may contribute to different MDs, including diabetes, obesity, or steatosis resistance (33, 89, 90).”
BackgroundDeficiency of TNFα Converting Enzyme (TACE/ADAM17) Causes a Lean, Hypermetabolic Phenotype in Mice
Gelling, R. W., Yan, W., Al-Noori, S., Pardini, A., Morton, G. J., Ogimoto, K., Schwartz, M. W., & Dempsey, P. J. (2008) · Endocrinology · doi:10.1210/en.2008-0775 · Cited by 74
Hypothalamic Leucine Metabolism Regulates Liver Glucose Production
Su, Y., Lam, T. K. T., He, W., Pocai, A., Bryan, J., Aguilar‐Bryan, L., & Juárez, R. G. (2011) · Diabetes · doi:10.2337/db11-0857 · Cited by 83
“Consistent with a homeostatic loop, the central effects of leucine described herein appear to oppose its peripheral actions on insulin signaling and on gluconeogenesis (2,38,50).”
BackgroundTuberous Sclerosis Complex-1 Deficiency Attenuates Diet-Induced Hepatic Lipid Accumulation
Kenerson, H. L., Yeh, M. M., & Yeung, R. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018075 · Cited by 70
“steatosis all share in the dysregulation of the Akt/mTOR pathway [21] [22] [23].”
BackgroundTandon, P., Gallo, C. A., Khatri, S., Barger, J. F., Yepiskoposyan, H., & Plas, D. R. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013629108 · Cited by 71
“S6K1 also functions in hormonal control of circulating glucose through effects in insulin-responsive tissues—S6K1 mice are glucose intolerant and exhibit increased blood glucose levels when fed a high fat diet (15).”
BackgroundBerberine modulates insulin signaling transduction in insulin-resistant cells
Liu, L., Cheung, S. C. K., Lan, L., Ho, S. K. S., Xu, H., Chan, J. C. N., & Tong, P. C. Y. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.12.027 · Cited by 80
Tzatsos, A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.027748 · Cited by 74
Sacco, A., Morcavallo, A., Pandini, G., Vigneri, R., & Belfiore, A. (2009) · Endocrinology · doi:10.1210/en.2009-0377 · Cited by 82
“was mirrored by IRS-1 phosphorylation on Ser-636/Ser-639 and Ser-307 (32).”
BackgroundInfluentialα-Lipoic acid regulates AMP-activated protein kinase and inhibits insulin secretion from beta cells
Targonsky, E. D., Dai, F. F., Koshkin, V., Karaman, G., Gyulkhandanyan, A. V., Zhang, Y., Chan, C. B., & Wheeler, M. B. (2006) · Diabetologia · doi:10.1007/s00125-006-0265-9 · Cited by 80
“The fact that p70 s6k knock-out mice have reduced GSIS [41] may be a reflection of a total-body loss of this enzyme and thus is likely to include contributions from the effects of p70 s6k deficiency in other tissues, including enhanced insulin sensitivity in the periphery [45].”
BackgroundCell type specificity of PI3K signaling in Pdk1- and Pten-deficient brains
Chalhoub, N., Zhu, G. G., Zhu, X., & Baker, S. J. (2009) · Genes & Development · doi:10.1101/gad.1799609 · Cited by 78
“S6K can phosphorylate and inhibit IRS1, creating a negative feedback loop that limits insulin and IGF receptor signaling through the PI3K pathway (Um et al. 2004).”
BackgroundIKKβ suppression of TSC1 function links the mTOR pathway with insulin resistance
Hung (1998) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000065 · Cited by 75
“Remarkably, S6k1-deficient mice are protected against nutritionally and genetically driven insulin resistance (11), and genetic loss of either tuberous sclerosis 1 (TSC1) or tuberous sclerosis 2 (TSC2) results in insulin resistance by increasing the phosphorylation of IRS1 at Ser302 (3), suggesting that hyperactivatio…”
BackgroundSmall, L., Brandon, A. E., Turner, N., & Cooney, G. J. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00337.2017 · Cited by 72
Mitochondrial longevity pathways
Raffaello, A., & Rizzuto, R. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.10.007 · Cited by 72
“mice, knocking out S6K protects against age- and diet-induced obesity [74] and induces life span extension [75], modulating the same genes as”
BackgroundFunctional genomic analysis unravels a metabolic-inflammatory interplay in adrenoleukodystrophy
Schlüter, A., Espinosa, L., Fourcade, S., Galino, J., López, E., Ilieva, E., Morató, L., Asheuer, M., Cook, T., McLaren, A., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/ddr536 · Cited by 72
“Fatty acids (FAs) can mediate insulin desensitization associated with the phosphorylation of IRS1 on serine 307 (17,20,21).”
BackgroundInfluentialSoliman, G. A., Acosta‐Jaquez, H. A., & Fingar, D. C. (2010) · Lipids · doi:10.1007/s11745-010-3488-y · Cited by 70
“Antibodies The following antibodies were purchased from Cell Signaling Technology (Danvers, MA, USA): P-S6K1-T389 (rabbit monoclonal 108D2); P-mTOR-S2481, HSL, ATGL, MGL.”
InfluentialPAS kinase is required for normal cellular energy balance
Hao, H.-X., Cardon, C. M., Swiatek, W., Cooksey, R. C., Smith, T., Wilde, J., Boudina, S., Abel, E. D., McClain, D. A., & Rutter, J. P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705407104 · Cited by 81
Tremblay, F., Jacques, H., & Marette, A. (2005) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/01.mco.0000172589.55434.03 · Cited by 71
Targeting Intermediary Metabolism in the Hypothalamus as a Mechanism to Regulate Appetite
Lopaschuk, G. D., Ussher, J. R., & Jaswal, J. S. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002428 · Cited by 81
Novel roles of mechanistic target of rapamycin signaling in regulating fetal growth†
Gupta, M. B., & Jansson, T. (2018) · Biology of Reproduction · doi:10.1093/biolre/ioy249 · Cited by 74
Metabolic Reprogramming in Dietary Restriction
Anderson, R. M., & Weindruch, R. (2006) · Interdisciplinary Topics in Gerontology · doi:10.1159/000096554 · Cited by 67
“Reduced TOR signaling in mice by knockout of the TOR effector S6K1 increases FAO and negatively regulates insulin signaling [26].”
BackgroundSürücü, B., Bozulic, L., Hynx, D., Parcellier, A., & Hemmings, B. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803053200 · Cited by 85
Carson, R. P., Fu, C., Winzenburger, P., & Ess, K. C. (2013) · Human Molecular Genetics · doi:10.1093/hmg/dds414 · Cited by 70
“Alternatively, increased mTORC1 activates a negative feedback loop from p70S6K that inhibits IRS-1, thus preventing the PI3-Kinase-dependent activation of mTORC2 (52,53).”
BackgroundBae, E. J., Xu, J., Oh, D. Y., Bandyopadhyay, G., Lagakos, W. S., Keshwani, M., & Olefsky, J. M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.365544 · Cited by 68
“Although it has been shown that phosphorylation of IRS-1 Ser307 was decreased in S6K1 depletedHela cells (7), this was not affected by S6K knock down in our model.”
BackgroundThe mTOR Signaling Pathway in Myocardial Dysfunction in Type 2 Diabetes Mellitus
Suhara, T., Baba, Y., Shimada, B. K., Higa, J. K., & Matsui, T. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0865-4 · Cited by 72
Nutrient sensor links obesity with diabetes risk
Patti, M., & Kahn, B. B. (2004) · Nature Medicine · doi:10.1038/nm1004-1049 · Cited by 70
Xie, J., & Herbert, T. P. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0874-4 · Cited by 72
“The age-related decrease in b-cell mass observed in bTSC2-/- mice is likely due to the prolonged hyper-activation of mTORC1 resulting in feedback inhibition, possibly through S6K-dependent phosphorylation of IRS2.”
BackgroundInfluentialPRLR Regulates Hepatic Insulin Sensitivity in Mice via STAT5
Yu, J., Xiao, F., Zhang, Q., Liu, B., Guo, Y., Lv, Z., Xia, T., Chen, S., Li, K., Du, Y., et al. (2013) · Diabetes · doi:10.2337/db13-0182 · Cited by 72
“Although it has been shown that mTOR/S6K1 is part of signaling downstream of IR via Akt, mTOR/S6K1 can also have negative feedback effects on insulin signaling (44), which is consistent with our observations demonstrating the effects of mTOR/S6K1 on insulin sensitivity regulation.”
ResultAnnexins—Coordinators of Cholesterol Homeostasis in Endocytic Pathways
Rentero, C., Blanco‐Muñoz, P., Meneses‐Salas, E., Grewal, T., & Enrich, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051444 · Cited by 72
“In support of this model, increased dietary uptake of lipids in mice upregulated mTORC1 activity [119,120].”
BackgroundRole of TSC–mTOR pathway in diabetic nephropathy
Inoki, K. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.09.028 · Cited by 73
Rapamycin-induced metabolic defects are reversible in both lean and obese mice
Liu, Y., Diaz, V., Fernandez, E., Strong, R., Ye, L., Baur, J. A., Lamming, D. W., Richardson, A., & Salmon, A. B. (2014) · Aging · doi:10.18632/aging.100688 · Cited by 68
“For example, chronic activation of mTORC1 signaling in obesity is thought to play a significant role in the development of insulin resistance in muscle, adipose and liver tissue [2-4].”
BackgroundmTOR Inhibitor Therapy and Metabolic Consequences: Where Do We Stand?
Kezić, A., Popović, L., & Lalic, K. S. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/2640342 · Cited by 72
“The direct phosphorylation of IRS1 by the mTOR-S6K1 pathway, which promotes IRS1 degradation and PI3K/Akt downregulation, has already been mentioned [31, 32, 40].”
BackgroundDu, H., Wang, Q., & Yang, X. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b06927 · Cited by 70
The stress-responsive protein REDD1 and its pathophysiological functions
Kim, J., Kwon, Y., & Kim, Y. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01056-3 · Cited by 255
Imidacloprid, a neonicotinoid insecticide, induces insulin resistance
Kim, J., Park, Y., Yoon, K. S., Clark, J. M., & Park, Y. (2013) · The Journal of Toxicological Sciences · doi:10.2131/jts.38.655 · Cited by 71
“Treatment with imidacloprid significantly reduced insulin stimulated activation of S6K, a downstream target of AKT, further suggesting AKT-mediated impairment of insulin signaling by imidacloprid in these models (Um et al., 2004; Manning, 2004; Harrington et al., 2004).”
BackgroundWeigert, C., Kron, M., Kalbacher, H., Pohl, A. K., Runge, H., Häring, H.-U., Schleicher, E., & Lehmann, R. (2008) · Molecular Endocrinology · doi:10.1210/me.2008-0102 · Cited by 66
mTORC1 signaling in energy balance and metabolic disease
Catania, C., Binder, E., & Cota, D. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.208 · Cited by 76
Pimentel, G. D., Lira, F. S., Neto, J. C. R., de Oliveira, J. L., Hachul, A. C. L., Souza, G. I. H., do Carmo, M. D. G. T., dos Santos, R. V. T., de Mello, M. T., Tufik, S., et al. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.12.003 · Cited by 72
“Furthermore, obesity is also associated with increasedmTOR activity, and a deficiency of S6K1 can protect animals against diet-induced obesity and insulin resistance [19,20].”
BackgroundA possible link between BDNF and mTOR in control of food intake
Takei, N., Furukawa, K., Hanyu, O., Sone, H., & Nawa, H. (2014) · Frontiers in Psychology · doi:10.3389/fpsyg.2014.01093 · Cited by 67
Elghazi, L., Balcázar, N., Blandino-Rosano, M., CRAS-MÉNEUR, C. M. H., Fátrai, S., Gould, A. P., Chi, M. M.-Y., Moley, K. H., & Bernal‐Mizrachi, E. (2010) · Diabetes · doi:10.2337/db09-0851 · Cited by 69
“Recent findings demonstrate that S6K activation in states of nutrient overload modulates insulin sensitivity by negatively regulating IRS1 function under conditions of nutrient overload (15-17; 22).”
BackgroundMethodZhao, X., Petrashen, A. P., Sanders, J. A., Peterson, A. L., & Sedivy, J. M. (2019) · Aging Cell · doi:10.1111/acel.12947 · Cited by 72
“In agreement, S6K1 deletion in mice, which impairs one mTORC1‐ activated downstream pathway, enhanced FAO and protected an‐ imals from obesity (Um et al., 2004).”
BackgroundmTOR controls ChREBP transcriptional activity and pancreatic β cell survival under diabetic stress
Chau, G. C., Im, D. U., Kang, T. M., Bae, J. M., Kim, W., Pyo, S., Moon, E.-Y., & Um, S. H. (2017) · Journal of Cell Biology · doi:10.1083/jcb.201701085 · Cited by 67
“In addition, mice lacking S6K1, a downstream effector of mTORC1, display hypoinsulinemia, decreased β cell size, and enhanced insulin sensitivity (Pende et al., 2000; Um et al., 2004).”
BackgroundSelf-citationAdipose mTORC1 Suppresses Prostaglandin Signaling and Beige Adipogenesis via the CRTC2-COX-2 Pathway
Zhang, X., Luo, Y., Wang, C., Ding, X., Yang, X., Wu, D., Silva, F. D., Yang, Z., Zhou, Q., Wang, L., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.08.055 · Cited by 77
“Several studies agree that adipose inhibition of mTORC1 leads to browning of WAT and that overactivation of mTORC1 in adipose tissue suppresses thermogenesis and exacerbates diet-induced obesity and insulin resistance in mice (Liu et al., 2014; Polak et al., 2008; Um et al., 2004; Wada et al., 2016).”
BackgroundEndoplasmic reticulum stress in insulin resistance and diabetes
Guerrero-Hernández, A., León-Aparicio, D., Chávez‐Reyes, J., Olivares-Reyes, J. A., & DeJesus, S. (2014) · Cell Calcium · doi:10.1016/j.ceca.2014.08.006 · Cited by 70
Aging signaling pathways and circadian clock-dependent metabolic derangements
Tevy, M. F., Giebultowicz, J., Pincus, Z., Mazzoccoli, G., & Vinciguerra, M. (2013) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.12.002 · Cited by 66
Leontieva, O. V., Demidenko, Z. N., & Blagosklonny, M. V. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.178 · Cited by 68
The Cullin7 E3 ubiquitin ligase: A novel player in growth control
Sarikas, A., Xu, X., Field, L. J., & Pan, Z. (2008) · Cell Cycle · doi:10.4161/cc.7.20.6922 · Cited by 74
Makki, K., Taront, S., Molendi-Coste, O., Bouchaert, E., Neve, B., Eury, E., Lobbens, S., Labalette, M., Duez, H., Staels, B., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092684 · Cited by 65
“mTOR signaling pathway is constitutively activated in obesity, leading to insulin resistance [2,3].”
Background
Metadata
- Authors
- Um, S. H., Frigerio, F., Watanabe, M., Picard, F., Joaquin, M., Sticker, M., Fumagalli, S., Allegrini, P. R., Kozma, S. C., Auwerx, J., & Thomas, G.
- Affiliations
- Friedrich Miescher Institute (CH)
- Centre National de la Recherche Scientifique (FR)
- Novartis (Switzerland) (CH)
- Corresponding author
- Thomas, George
- ORCID
- Venue
- Nature
- Published
- 2004-08-11
- Volume
- 431
- Issue
- 7005
- Pages
- 200-205
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2107674876
- Cited by
- 1,677
- References
- 58
- Citations by year
- 2026: 29 · 2025: 30 · 2024: 36 · 2023: 53 · 2022: 57 · 2021: 68 · 2020: 59 · 2019: 56 · 2018: 74 · 2017: 71 · 2016: 84 · 2015: 99 · 2014: 86 · 2013: 101 · 2012: 134
- FWCI
- 25.05
- Type
- journal article
- Language
- en
- Open access
- green
- infoscience.epfl.ch
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- S6K1, mTOR signaling, insulin sensitivity, insulin resistance, obesity, high-fat diet, fatty acid beta-oxidation, IRS-1 phosphorylation, beta-cell mass, impaired glucose tolerance, ob/ob mice, leptin deficiency
- MeSH terms
- Aging, Animals, Blood Glucose, Dietary Fats, Enzyme Activation, Fasting, Fatty Acids, Nonesterified, Insulin, Insulin Resistance, Lipolysis, Male, Mice, Inbred C57BL, Obesity, Oxidation-Reduction, Phosphoproteins, Phosphorylation, Receptor, Insulin, RNA, Messenger, Signal Transduction, Gene Deletion, Adipocytes, Mice, Knockout, Ribosomal Protein S6 Kinases, 70-kDa, Mice, Insulin Receptor Substrate Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.